Position in ZTS
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$375,971
-$241,439 QoQ
Shares Held
5,232
+0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#853
of 1,412 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Premier Path Wealth Partners, LLC holds $704,010 across 2 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (53.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
5,232 | $375,971 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
18,265 | $328,039 |
All Filings in ZTS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $375,971 | 5,232 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $617,410 | 5,223 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $481,638 | 3,828 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $738,916 | 5,050 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $844,313 | 5,414 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $913,642 | 5,549 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $877,866 | 5,388 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,070,291 | 5,478 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $960,761 | 5,542 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $898,674 | 5,311 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $1,141,785 | 5,785 | Shares | Sole | 2024-01-12 | |
| No filing history on record for this holder in this stock. | ||||||